© Reuters. The Johnson & Johnson logo in a photo from the Reuters archive
(Reuters) – Johnson & Johnson said on Thursday that a single dose of its COVID-19 vaccine shows strong and sustained immunity to Delta and other highly prevalent strains.
The company said the data showed that the robust immune response lasted at least eight months.
(Prepared by Muhammad Al-Yamani for the Arabic Bulletin)
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.